Research Papers

25 of 2983 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
COVID-19 vaccine effectiveness by HIV status and history of injection drug use: a test-negative analysis.
Puyat JH; Wilton J; Fowokan A; Janjua NZ; Wong J; Grennan T; Chambers C; Kroch A; Costiniuk CT; Cooper CL; Lauscher D; Strong M; Burchell AN; Anis A; Samji H; COVAXHIV Study Team.
J Int AIDS Soc (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Virtual case management: a differentiated approach to HIV prevention, treatment, and care.
Zinck MJ; Minichiello SN; Fick CA; Sawry S; Fonner VA.
AIDS (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The hidden effects of COVID-19 on HIV services in Zanzibar: country report.
Mshenga MM; Khalid FJ; Haji SH; Ali TB; Mohamed KA; Damian DJ.
AIDS Res Ther (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Measuring the performance of HIV self-testing at private pharmacies in Kenya: a cross-sectional study.
Ortblad KF; Kwach B; Zhang S; Asewe M; Ongwen PA; Malen RC; Harkey K; Odoyo J; Gathii P; Rota G; Sharma M; Were DK; Ngure K; Omollo V; Bukusi EA.
J Int AIDS Soc (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Understanding health outcome drivers among adherence club patients in clinics of Gauteng, South Africa: a structural eq…
Tshuma N; Ngbede ED; Nyengerai T; Mtapuri O; Moyo S; Mphuthi DD; Nyasulu P.
AIDS Res Ther (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Predictive model for diagnostic yield of bone marrow examination in patients with HIV infection having fever of unknown…
Noiperm P; Saelue P.
AIDS (Unknown)
Published: 2023
2/6 Transparent
Immunogenicity of tetanus, diphtheria and acellular pertussis vaccination among pregnant women living with and without …
Nunes MC; Tamblyn A; Jose L; Ntsimane M; Lerotholi N; Machimana C; Taylor A; Laher F; Madhi SA.
AIDS (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Estimating prevalence and modelling correlates of HIV test positivity among female sex workers, men who have sex with m…
Dwomoh D; Wurie I; Harding Y; Sedzro KM; Kandeh J; Tagoe H; Addo C; Arhinful DK; Sessay ARC; Kamara JL; Mansaray K; Ampofo WK.
AIDS Res Ther (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Progress with induction of HIV broadly neutralizing antibodies in the Duke Consortia for HIV/AIDS Vaccine Development.
Haynes BF; Wiehe K; Alam SM; Weissman D; Saunders KO.
Curr Opin HIV AIDS (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Discovery medicine - the HVTN's iterative approach to developing an HIV-1 broadly neutralizing vaccine.
Martin TM; Robinson ST; Huang Y.
Curr Opin HIV AIDS (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
'Immunization during ART and ATI for HIV-1 vaccine discovery/development'.
Stamatatos L.
Curr Opin HIV AIDS (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Accelerating HIV vaccine development through meaningful engagement of local scientists and communities.
Chinyenze K; Nduati E; Muturi-Kioi V.
Curr Opin HIV AIDS (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Cross-sectional HIV and HCV cascades of care across the regions of Ukraine between 2019 and 2020: findings from the CAR…
Fursa O; Reekie J; Kuzin I; Hetman L; Kryshchuk A; Starychenko O; Hrytsaiuk N; Khodus I; Nyzhnyk A; Rakhuba V; Kovalevska M; Maistat T; Pryhoda I; Ahieieva M; Varvarovska O; Valdenmaiier O; Lundgren J; Peters L; CARE study group.
J Int AIDS Soc (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Tenofovir diphosphate in dried blood spots and HIV-1 resistance in South Africa.
Singh Y; Castillo-Mancilla J; Madimabe R; Jennings L; Ferraris CM; Robbins RN; Anderson PL; Remien RH; Orrell C.
AIDS Res Ther (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Virological and immunological correlates of HIV posttreatment control after temporal antiretroviral therapy during acut…
van Paassen PM; van Pul L; van der Straten K; Buchholtz NVJE; Grobben M; van Nuenen AC; van Dort KA; Boeser-Nunnink BD; van den Essenburg MD; Burger JA; van Luin M; Jurriaans S; Sanders RW; Swelsen WT; Symons J; Klouwens MJ; Nijhuis M; van Gils MJ; Prins JM; de Bree GJ; Kootstra NA.
AIDS (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Dolutegravir use over 48 weeks is not associated with worsening insulin resistance and pancreatic beta cell function in…
Mulindwa F; Castelnuovo B; Brusselaers N; Nabwana M; Bollinger R; Buzibye A; Agnes Odongpiny EL; Kiguba R; Schwarz JM.
AIDS Res Ther (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
A structural equation modeling approach to investigate HIV testing willingness for men who have sex with men in China.
Jiang H; He W; Pan H; Zhong X.
AIDS Res Ther (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Immunogenicity and reactogenicity of yellow fever vaccine in people with HIV.
Motta E; Camacho LAB; Cunha M; de Filippis AMB; Lima SMB; Costa M; Pedro L; Cardoso SW; Cortes FH; Giacoia-Gripp CBW; Morata M; Nazer S; Moreira RI; de Oliveira Souza MC; Mendes YS; Souza Azevedo A; Dos Santos Alvez N; Grinsztejn B; Coelho LE.
AIDS (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
A systematic review of qualitative research on recently acquired HIV.
Nicholls EJ; Policek N; Volny-Anne A; Spire B; Burns F; Ruiz-Burga E; Tariq S; for CASCADE Collaboration.
AIDS (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Sustained response following BTK inhibitors based treatment in HIV-related primary central nervous system lymphoma: cas…
Zhou Y; Wang X; Lin X; Wang J; Yan X; Wen Y.
AIDS Res Ther (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Community- and individual-level correlates of HIV incidence in HPTN 071 (PopART).
Skalland T; Ayles H; Bock P; Bwalya J; Shanaube K; Kasese N; Dupré M; Kosloff B; Floyd S; Wilson E; Moore A; Eshleman S; Fidler S; Hayes R; Donnell D; HPTN 071 (PopART) Study Team.
J Int AIDS Soc (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
The AIDS and Cancer Specimen Resource (ACSR): HIV malignancy specimens and data available at no cost.
Silver S; Schmelz M.
AIDS Res Ther (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Rescue therapy with an albuvirtide-based antiretroviral regimen in an HIV-infected child with multidrug resistance and …
Tang W; Song XY; Cao J; Liu C; Zheng F.
AIDS Res Ther (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Assessment of satisfaction with antiretroviral drugs and the need for long-acting injectable medicines among people liv…
Ishihara M; Hikasa S; Tsukiji M; Kunimoto Y; Nobori K; Kimura T; Onishi K; Yamamoto Y; Haruta K; Kashiwabara Y; Fujii K; Shimabukuro S; Watanabe D; Tsurumi H; Suzuki A.
AIDS Res Ther (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Levels of health literacy among people living with HIV in outpatient care: a cross-sectional study from Denmark.
Rodkjaer LØ; Storgaard M; Sørensen NT; Schougaard LMV.
AIDS Res Ther (Unknown)
Published: 2023
3/6 Transparent
Funding Declared